Healthcare / Medical Care FacilitiesHelsinki
$8.01
-0.11 (-1.34%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 24% · confianza 25%
FCF escenarios
weak_data · normalized FCF $155.4M · quality 70.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
44/100
C
Piotroski
7/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$1.0B
P/E
13.1x
↓EV/EBITDA
6.5x
↓ROE
15.9%
↑Gross Margin
60.1%
↑Debt/Equity
0.99
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+0.5%
FCF CAGR
+23.9%
FCF margin
12.2%
FCF / Net income
1.68x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $1.28B · net income $92.6M · FCF $155.4M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.28B | $1.28B | $1.34B | $1.29B | $1.26B |
| Net Income | $92.6M | $92.6M | $71.7M | $-42.2M | $24.4M |
| EBITDA | $232.7M | $232.7M | $217.4M | $90.7M | $143.7M |
| EPS | 0.73 | 0.73 | 0.57 | -0.33 | 0.19 |
| Gross Margin | 60.1% | 60.1% | 59.0% | 58.3% | 58.2% |
| Operating Margin | 11.0% | 11.0% | 8.9% | 5.5% | 5.2% |
| Net Margin | 7.2% | 7.2% | 5.4% | -3.3% | 1.9% |
| Balance Sheet | |||||
| Debt/Equity | 0.99 | 0.99 | 1.04 | 1.23 | 1.03 |
| Current Ratio | 0.54 | 0.54 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $155.4M | $155.4M | $184.1M | $116.8M | $81.7M |
| Returns | |||||
| ROE | 15.9% | 15.9% | 13.1% | -8.2% | 4.1% |
| Valuation | |||||
| P/E | 13.13 | 13.13 | 18.81 | — | 34.32 |
| EV/EBITDA | 6.54 | 6.54 | 8.57 | 17.79 | 9.71 |
| P/B | 1.74 | 1.74 | 2.48 | 1.97 | 1.40 |
| Growth & Yield | |||||
| Revenue Growth | -4.6% | -4.6% | 4.2% | 2.2% | — |
| EPS Growth | 28.1% | 28.1% | 272.7% | -273.7% | — |
| Dividend Yield | 7.9% | 7.9% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-0.9%
EPS terminal req.
$0.71
Spread vs growth
29.0%
5Y implied EPS CAGR
3.3%
EPS terminal req.
$0.86
Spread vs growth
24.7%
10Y implied EPS CAGR
6.6%
EPS terminal req.
$1.39
Spread vs growth
21.5%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-26.0%
Start / end P/E
21.5x → 11.1x
EPS bridge
0.57 → 0.73
Residual
-13.6%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.